Clear Search sequence regions


Sizes of these terms reflect their relevance to your search.

The discovery that a range of myeloproliferative diseases and leukemias are associated with Janus Kinase (JAK) mutations has highlighted the importance of JAK/STAT signalling in disease and sparked a renewed interest in developing JAK inhibitors. In vitro kinase assays are the most direct and quantitative method to assess mutant forms of JAK for altered enzymatic properties as well as verifying and quantifying the affinity and efficacy of potential inhibitors. Here, we describe protocols for heterologous expression and purification of JAK kinases from insect cells, assays to determine the activity of these purified kinases, and finally inhibition assays to determine the effectiveness of potential inhibitors.

Citation

Jeffrey J Babon, James M Murphy. In vitro JAK kinase activity and inhibition assays. Methods in molecular biology (Clifton, N.J.). 2013;967:39-55

Expand section icon Mesh Tags

Expand section icon Substances


PMID: 23296720

View Full Text